(Q46525400)
Statements
Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response (English)
Anthony H Schapira
Mona Sadeghian
Banu C Tel
Sarah Rose